IHT Wealth Management LLC Has $951,000 Holdings in Teladoc Health, Inc. (NYSE:TDOC)

IHT Wealth Management LLC lifted its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 87.2% during the 1st quarter, HoldingsChannel reports. The fund owned 5,230 shares of the health services provider’s stock after acquiring an additional 2,436 shares during the quarter. IHT Wealth Management LLC’s holdings in Teladoc Health were worth $951,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. tru Independence LLC acquired a new position in shares of Teladoc Health in the fourth quarter valued at about $23,996,000. First National Bank of South Miami grew its stake in shares of Teladoc Health by 560.0% in the fourth quarter. First National Bank of South Miami now owns 132 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 112 shares in the last quarter. Berman Capital Advisors LLC grew its stake in shares of Teladoc Health by 234.9% in the fourth quarter. Berman Capital Advisors LLC now owns 144 shares of the health services provider’s stock valued at $28,000 after acquiring an additional 101 shares in the last quarter. TFO TDC LLC bought a new stake in Teladoc Health during the first quarter worth about $27,000. Finally, Wagner Wealth Management LLC bought a new stake in Teladoc Health during the first quarter worth about $37,000. Institutional investors and hedge funds own 77.81% of the company’s stock.

TDOC has been the subject of several recent analyst reports. Truist cut their price objective on shares of Teladoc Health from $275.00 to $206.00 in a research report on Monday, May 10th. Zacks Investment Research raised shares of Teladoc Health from a “sell” rating to a “hold” rating and set a $191.00 price objective for the company in a research report on Thursday, April 1st. Credit Suisse Group cut their price objective on shares of Teladoc Health from $300.00 to $264.00 and set an “outperform” rating for the company in a research report on Friday, April 30th. KeyCorp cut their price objective on shares of Teladoc Health from $270.00 to $220.00 and set an “overweight” rating for the company in a research report on Thursday, April 29th. They noted that the move was a valuation call. Finally, Needham & Company LLC initiated coverage on shares of Teladoc Health in a research report on Thursday, April 15th. They set a “buy” rating and a $235.00 price objective for the company. Twelve analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $238.56.

In other news, SVP Daniel Trencher sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, July 12th. The shares were sold at an average price of $160.30, for a total transaction of $320,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Arnnon Geshuri sold 3,959 shares of the firm’s stock in a transaction that occurred on Wednesday, May 26th. The stock was sold at an average price of $146.40, for a total transaction of $579,597.60. Following the sale, the insider now directly owns 92,958 shares of the company’s stock, valued at approximately $13,609,051.20. The disclosure for this sale can be found here. Insiders have sold a total of 34,368 shares of company stock valued at $5,323,435 in the last three months. Insiders own 6.47% of the company’s stock.

NYSE:TDOC opened at $153.32 on Thursday. The firm has a market cap of $23.69 billion, a P/E ratio of -29.77 and a beta of 0.27. The firm’s 50 day moving average price is $152.85. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.96 and a quick ratio of 3.74. Teladoc Health, Inc. has a fifty-two week low of $129.74 and a fifty-two week high of $308.00.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, April 28th. The health services provider reported $0.13 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.57) by $0.70. The business had revenue of $453.68 million during the quarter, compared to the consensus estimate of $452.12 million. Teladoc Health had a negative net margin of 47.93% and a negative return on equity of 0.60%. The company’s revenue for the quarter was up 150.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.40) EPS. As a group, research analysts expect that Teladoc Health, Inc. will post -3.03 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, chronic condition management, expert medical services, behavioral health solutions, guidance and support, and platform and program services.

Featured Article: CD Ladder

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.